CPT Medical a surgical pack and kit manufacturing firm based in Greenville, SC, is now shipping nasal wash COVID-19 testing kits that are available throughout the US. With 54,000 test kits in production for allocation to hospitals, nursing homes, and physician’s offices by the end of next week, CPT Medical is scheduled to release 95,000 test kits for patient testing in approximately three weeks.
To order COVID-19 test kits or for more information, healthcare providers can call 866.584.3713 or visit www.cptmed.com.
Developed
in CPT Medical’s FDA registered facility under CDC guidelines, the tests
offered are bulk kits for nursing homes, hospitals, laboratories, and large
physician’s offices as well as individual kits for laboratories. Produced in
collaboration with Premier Medical Laboratory Services, a COLA and CLIA regulated laboratory, the
tests serve as a COVID-19 diagnostic testing and Respiratory Pathogen Profile (RPP)
kits.
Currently
in development at the CPT Medical facility for telehealth services are home
testing kits to be ordered by physicians to their patients. This development will
help mitigate transmission of the virus between patients and healthcare
providers. Once the development process is completed for the in-home testing
kits, they will not be available to the general public directly, but will be
accessible by physicians only for their patients.
With this molecular diagnostic test, the presence of COVID-19 is detected through a nasal pharyngeal swab and results will be provided within 24 – 48 hours. Expedited detection of the virus will enable further efficiency in response time to employ the appropriate courses of action for containment of the virus.
According
to recent statements by the FDA, rapid detection of COVID-19 cases in
the United States requires wide availability of diagnostic testing to
control the emergence of this rapidly spreading, severe illness.
Viruses and bacteria that can be accurately diagnosed with this testing include:
|
Viruses Detected:
Coronavirus COVID 19 (SARS-CoV-2)
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
Enterovirus D68
Enterovirus PAN
Metapneumovirus
Parainfluenza Virus 1
Parainfluenza Virus 2
Parainfluenza Virus 3
Parainfluenza Virus 4
Influenza A PAN
Influenza A H1 2009
Influenza A H3
Influenza B PAN
|
Adenovirus 1
Adenovirus 2
Respiratory Syncytial Virus B
Rhinovirus 1
Herpes Virus 4 – Epstein-Barr Virus
Herpes Virus 5 – Cytomegalovirus
Herpes Virus 6
Respiratory Syncytial Virus A
|
Bacteria Tested:
Bordetella bonchispetica, parapertussis, pertussis
Bordetella pertussis
Haemophilus influenzae
Klebsiella pneumoniae
Legionella pneumophila
Mycoplasma pneumoniae
Staphylococcus aureus
Streptococcus pneumoniae
Chlamydophila pneumoniae
|
Benefits of respiratory virus detection
- Widespread use of precise respiratory virus detection has improved diagnostic accuracy
- Diagnostic testing has been linked to a more focused use of antimicrobials
- Testing may also help determine if viral infection is associated with bacterial coinfections.
To order COVID-19 test kits or for more information, healthcare providers can call 866.584.3713 or visit www.cptmed.com.
UPDATED: CPT Medical Services Has Critical COVID-19 Kits Available for Physicians
CPT Medical a surgical pack and kit manufacturing firm based in Greenville, SC, is now shipping nasal wash COVID-19 testing kits that are available throughout the US. With 54,000 test kits in production for allocation to hospitals, nursing homes, and physician’s offices by the end of next week, CPT Medical is scheduled to release 95,000 test kits for patient testing in approximately three weeks.
To order COVID-19 test kits or for more information, healthcare providers can call 866.584.3713 or visit www.cptmed.com.
Developed in CPT Medical’s FDA registered facility under CDC guidelines, the tests offered are bulk kits for nursing homes, hospitals, laboratories, and large physician’s offices as well as individual kits for laboratories. Produced in collaboration with Premier Medical Laboratory Services, a COLA and CLIA regulated laboratory, the tests serve as a COVID-19 diagnostic testing and Respiratory Pathogen Profile (RPP) kits.
Currently in development at the CPT Medical facility for telehealth services are home testing kits to be ordered by physicians to their patients. This development will help mitigate transmission of the virus between patients and healthcare providers. Once the development process is completed for the in-home testing kits, they will not be available to the general public directly, but will be accessible by physicians only for their patients.
With this molecular diagnostic test, the presence of COVID-19 is detected through a nasal pharyngeal swab and results will be provided within 24 – 48 hours. Expedited detection of the virus will enable further efficiency in response time to employ the appropriate courses of action for containment of the virus.
According to recent statements by the FDA, rapid detection of COVID-19 cases in the United States requires wide availability of diagnostic testing to control the emergence of this rapidly spreading, severe illness.
Viruses and bacteria that can be accurately diagnosed with this testing include:
Benefits of respiratory virus detection
To order COVID-19 test kits or for more information, healthcare providers can call 866.584.3713 or visit www.cptmed.com.
Related Articles
The Evolution And Validation Of The Metabolic Theory Of Cancer
Read MoreMastering the Art of Conscious Breathing
Read MoreImpact of Stress Hormones on Insulin Metabolism
Read More